Shuji Isaji

ORCID: 0000-0001-7868-4498
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatic and Hepatic Oncology Research
  • Pancreatitis Pathology and Treatment
  • Liver Disease and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Liver Disease Diagnosis and Treatment
  • Gallbladder and Bile Duct Disorders
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Neuroendocrine Tumor Research Advances
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gastrointestinal disorders and treatments
  • Renal Transplantation Outcomes and Treatments
  • Cancer Genomics and Diagnostics
  • Gastric Cancer Management and Outcomes
  • Appendicitis Diagnosis and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Gastrointestinal Tumor Research and Treatment
  • Renal cell carcinoma treatment
  • Abdominal vascular conditions and treatments
  • Liver physiology and pathology
  • Hepatitis C virus research
  • Transplantation: Methods and Outcomes
  • Complement system in diseases
  • Organ Donation and Transplantation
  • Venous Thromboembolism Diagnosis and Management

Mie University
2015-2024

Mie University Hospital
2006-2023

Mie Chukyo University
2023

Soka Municipal Hospital
2022

Amsterdam University Medical Centers
2021

University of Amsterdam
2021

Tsu City College
2018

Eastern Hepatobiliary Surgery Hospital
2014-2017

Second Military Medical University
2014-2017

Amsterdam UMC Location University of Amsterdam
2015

This statement was developed to promote international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC) which adopted by National Comprehensive Cancer Network (NCCN) in 2006, but has changed yearly and become more complicated. Based a symposium held during 20th meeting International Association Pancreatology (IAP) Sendai, Japan, 2016, presenters sought issues related BR-PDAC. We defined patients with BR-PDAC according three distinct dimensions:...

10.1016/j.pan.2017.11.011 article EN cc-by-nc-nd Pancreatology 2017-11-23

Abstract Background Although some retrospective studies have suggested the value of adjuvant therapy, no recommended standard exists in bile duct cancer. The aim this study was to test hypothesis that gemcitabine chemotherapy would improve survival probability resected Methods This a randomized phase III trial. Patients with cancer were assigned randomly and observation groups, which balanced respect lymph node status, residual tumour status location. Gemcitabine given intravenously at dose...

10.1002/bjs.10776 article EN British journal of surgery 2018-02-01

The prognosis of pancreatic cancer is defined by the histology and extent disease. Preoperative histologic diagnosis diagnostic imaging are fundamentals in managing disease, but it not rare to find unexpected peritoneal dissemination or liver metastasis at time operation. overall resectability rate 40% Japan. Resecting portal vein peripancreatic plexus were performed on patients who underwent pancreatectomy for invasive head pancreas. Long-term survival was only found pancreatectomy. Radical...

10.1097/00006676-200404000-00002 article EN Pancreas 2004-03-19

The Japan Pancreas Society performed a multiinstitutional, retrospective study of 1379 cases intraductal papillary mucinous tumor (IPMT) and 179 cystic (MCT) the pancreas. Clinicopathologic features postoperative long-term outcomes were investigated. IPMT most frequently found in men head In contrast, all patients with MCT women. Ovarian-type stroma only 42.2% cases. Prognostic indicators malignant included advanced age, positive symptoms, abundant mucous secretion, presence large nodules...

10.1097/00006676-200404000-00005 article EN Pancreas 2004-03-19

Purpose: To retrospectively evaluate the long-term results of radiofrequency (RF) ablation combined with chemoembolization (combination therapy) as compared hepatectomy for treatment early-stage hepatocellular carcinoma (HCC). Materials and Methods: The study was approved by institutional review board, informed consent waived. Patients HCC were included if they underwent either combination therapy or met following inclusion criteria: no previous HCC, three fewer tumors a maximum diameter 3...

10.1148/radiol.2471070818 article EN Radiology 2008-02-28

Abstract Background Optimal treatment types and prognosis for patients with borderline resectable pancreatic cancer (BRPC) remain unclear because of the lack studies involving large series patients. Methods We retrospectively analyzed various prognostic factors 624 BRPC (pancreatic head/body) treated from June 2002 to May 2007, by distributing questionnaires member institutions Japanese Society Pancreatic Surgery in 2010. was defined according National Comprehensive Cancer Network (NCCN)...

10.1007/s00534-013-0595-1 article EN Journal of Hepato-Biliary-Pancreatic Sciences 2013-03-13

This paper is part of the international consensus guidelines on chronic pancreatitis, presenting for interventional endoscopy.An working group with experts endoscopy evaluated 26 statements generated from evidence 9 clinically relevant questions. The Grading Recommendations Assessment, Development, and Evaluation approach was used to evaluate level evidence. To determine agreement, a nine-point Likert scale voting statements.Strong obtained 15 relating nine questions including recommendation...

10.1016/j.pan.2020.05.022 article EN cc-by-nc-nd Pancreatology 2020-07-10

Abstract Background In preparing the Japanese (JPN) guidelines for management of acute pancreatitis 2021, committee focused issues raised by results nationwide epidemiological survey in 2016 Japan. Method addition to a systematic search using previous JPN guidelines, papers published from January 2014 September 2019 were searched contents be covered based on concept GRADE system. Results Thirty‐six clinical questions (CQ) prepared 15 subject areas. Based facts that patients diagnosed with...

10.1002/jhbp.1146 article EN Journal of Hepato-Biliary-Pancreatic Sciences 2022-04-07

Summary There are three different diagnostic score systems for disseminated intravascular coagulation (DIC) established by the Japanese Ministry Health and Welfare (JMHW), International Society on Thrombosis Haemostasis (ISTH) Association Acute Medicine (JAAM). The JMHW criteria still used in Japan. In present study, all were to prospectively evaluate 413 patients with underlying diseases of DIC who treated at Mie University Hospital (JMHW, n= 166; ISTH, n=143; JAAM, n=291). odds ratio (95%...

10.1160/th10-05-0293 article EN Thrombosis and Haemostasis 2010-10-12
Janneke van Grinsven Sandra van Brunschot Olaf J. Bakker Thomas L. Bollen Marja A. Boermeester and 95 more Marco J. Bruno Cornelis H.C. Dejong Marcel G. W. Dijkgraaf Casper H.J. van Eijck Paul Fockens Harry van Goor Hein G. Gooszen Karen D. Horvath Krijn P. van Lienden Hjalmar C. van Santvoort Marc G. Besselink Mohamed Abdelhafez Roland Andersson A. Andren-Sandberg Stanley W. Ashley Marchien van Baal Todd H. Baron Claudio Bassi E. L. Bradley Markus W. Büchler Vincent C. Cappendijk R. Carter Richard Charnley Davi Neves Coelho Saxon Connor Patchen Dellinger Christos Dervenis J. Devière N. Doctor Vikas Dudeja Enqiang Mao J Escourrou Peter J. Fagenholz Gyula Farkas Christopher E. Forsmark Martin L. Freeman Patrick C. Freeny Jeremy French Helmut Frieß Timothy B. Gardner P. Goetzinger J. Haveman S. Hofker C W Imrie Shuji Isaji R. Isenmann E. Klar Johan S. Laméris Markus M. Lerch Patrick Lévy Keith D. Lillemoe Matthias Löhr Julia Mayerle Toshihiko Mayumi Anubhav Mittal J. Moessner Desiree E. Morgan Koenraad J. Mortelé William H. Nealon John P. Neoptolemos Vincent B. Nieuwenhuijs Isto Nordback Attila Oláh Kofi Oppong Robert Padbury George Papachristou Rowan W. Parks Jan‐Werner Poley Dejan Radenković Michael Raraty Beate Rau Vinciane Rebours Susanne Rische Michael Rünzi Nisha I. Sainani M. G. Sarr S. Schaapherder Stefan Seewald H Seifert Tooru Shimosegawa Stuart G. Silverman Vijay Singh Ajith K. Siriwardena William M. Steinberg R. Sutton K Takeda R. Timmer Santhi Swaroop Vege Rogier P. Voermans Jan J. De Waele Chun‐Hua Wang Andrew L. Warshaw Jens Werner Bas L. Weusten David C. Whitcomb

10.1016/j.hpb.2015.07.003 article EN publisher-specific-oa HPB 2015-12-20

The Japan Pancreas Society (JPS) published the fifth Japanese edition of General Rules for Study Pancreatic Cancer in 2002, same year that Union Internationale Contre le (UICC) its sixth edition. JPS had been revised, based on data from 18,629 cases carcinoma pancreas registered by (1981-1996) with goal making simple, easy to understand, and reliable predicting outcome. 2 classifications are compared analyzing 3979 resected patients tubular adenocarcinoma pancreatic head JPS, focusing...

10.1097/00006676-200404000-00003 article EN Pancreas 2004-03-19
Coming Soon ...